Adaptimmune Therapeutics Plc (ADAPY)
0.037
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Adaptimmune Therapeutics Max Drawdown (5Y) : 100.00% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 100.00% |
| August 31, 2026 | 100.00% |
| July 31, 2026 | 100.00% |
| June 30, 2026 | 100.00% |
| May 31, 2026 | 100.00% |
| April 30, 2026 | 100.00% |
| March 31, 2026 | 99.97% |
| February 28, 2026 | 99.83% |
| January 31, 2026 | 99.63% |
| December 31, 2025 | 99.63% |
| November 30, 2025 | 99.62% |
| October 31, 2025 | 99.62% |
| September 30, 2025 | 99.62% |
| August 31, 2025 | 99.47% |
| July 31, 2025 | 99.26% |
| June 30, 2025 | 98.37% |
| May 31, 2025 | 98.37% |
| April 30, 2025 | 98.37% |
| March 31, 2025 | 98.37% |
| February 28, 2025 | 96.45% |
| January 31, 2025 | 96.45% |
| December 31, 2024 | 96.45% |
| November 30, 2024 | 96.45% |
| October 31, 2024 | 96.57% |
| September 30, 2024 | 96.57% |
| Date | Value |
|---|---|
| August 31, 2024 | 96.57% |
| July 31, 2024 | 96.57% |
| June 30, 2024 | 96.57% |
| May 31, 2024 | 96.57% |
| April 30, 2024 | 96.57% |
| March 31, 2024 | 96.57% |
| February 29, 2024 | 96.57% |
| January 31, 2024 | 96.57% |
| December 31, 2023 | 96.57% |
| November 30, 2023 | 96.57% |
| October 31, 2023 | 96.57% |
| September 30, 2023 | 96.57% |
| August 31, 2023 | 96.57% |
| July 31, 2023 | 96.57% |
| June 30, 2023 | 96.57% |
| May 31, 2023 | 96.57% |
| April 30, 2023 | 96.57% |
| March 31, 2023 | 96.57% |
| February 28, 2023 | 96.57% |
| January 31, 2023 | 96.57% |
| December 31, 2022 | 96.57% |
| November 30, 2022 | 96.57% |
| October 31, 2022 | 96.57% |
| September 30, 2022 | 96.57% |
| August 31, 2022 | 96.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Oxford Biomedica Plc | 90.85% |
| Kiniksa Pharmaceuticals International Plc | 75.43% |
| Autolus Therapeutics Plc | 96.58% |
| Bicycle Therapeutics Plc | 94.11% |
| Scancell Holdings Plc | 99.64% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -73.88 |
| Beta (5Y) | 0.7520 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 722.9% |
| Historical Sharpe Ratio (5Y) | -0.0918 |
| Historical Sortino (5Y) | -0.9952 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 58.48% |